Literature DB >> 27392129

Mammary gland and radiation: Knowns and unknowns.

Lidia Luzhna1, Olga Kovalchuk1.   

Abstract

Effective breast cancer management and decreasing breast cancer fatalities is contingent upon reliable diagnostic procedures and treatment modalities, including those based on ionizing radiation. On the one hand, ionizing radiation is widely used for cancer diagnostics and therapy, on the other hand it is genotoxic cancer-causing agent. Here we discuss recent studies on the effects of low (diagnostic) and high (treatment) doses of ionizing radiation on healthy breast cells, breast cancer cells, and cancer cells resistant to common drug therapies.

Entities:  

Keywords:  breast cancer; epigenetics; gene expression; ionizing radiation; mammary gland; microRNA

Mesh:

Substances:

Year:  2016        PMID: 27392129      PMCID: PMC4968965          DOI: 10.1080/15384101.2016.1170262

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  22 in total

Review 1.  Inheritance of epigenetic aberrations (constitutional epimutations) in cancer susceptibility.

Authors:  Megan P Hitchins
Journal:  Adv Genet       Date:  2010       Impact factor: 1.944

2.  Hyper-radiosensitivity and induced radioresistance and bystander effects in rodent and human cells as a function of radiation quality.

Authors:  R Cherubini; V De Nadal; S Gerardi
Journal:  Radiat Prot Dosimetry       Date:  2015-05-06       Impact factor: 0.972

3.  Constitutional methylation of the BRCA1 promoter is specifically associated with BRCA1 mutation-associated pathology in early-onset breast cancer.

Authors:  Ee Ming Wong; Melissa C Southey; Stephen B Fox; Melissa A Brown; James G Dowty; Mark A Jenkins; Graham G Giles; John L Hopper; Alexander Dobrovic
Journal:  Cancer Prev Res (Phila)       Date:  2010-10-26

Review 4.  Assessing cancer risks of low-dose radiation.

Authors:  Leon Mullenders; Mike Atkinson; Herwig Paretzke; Laure Sabatier; Simon Bouffler
Journal:  Nat Rev Cancer       Date:  2009-08       Impact factor: 60.716

5.  p53-mediated activation of miRNA34 candidate tumor-suppressor genes.

Authors:  Guido T Bommer; Isabelle Gerin; Ying Feng; Andrew J Kaczorowski; Rork Kuick; Robert E Love; Yali Zhai; Thomas J Giordano; Zhaohui S Qin; Bethany B Moore; Ormond A MacDougald; Kathleen R Cho; Eric R Fearon
Journal:  Curr Biol       Date:  2007-07-26       Impact factor: 10.834

6.  Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest.

Authors:  Valery Tarasov; Peter Jung; Berlinda Verdoodt; Dmitri Lodygin; Alexey Epanchintsev; Antje Menssen; Gunter Meister; Heiko Hermeking
Journal:  Cell Cycle       Date:  2007-05-11       Impact factor: 4.534

7.  Radiation exposure from imaging tests in pediatric emergency medicine: a survey of physician knowledge and risk disclosure practices.

Authors:  Kathy Boutis; Jason Fischer; Stephen B Freedman; Karen E Thomas
Journal:  J Emerg Med       Date:  2014-03-31       Impact factor: 1.484

8.  Transcriptional activation of miR-34a contributes to p53-mediated apoptosis.

Authors:  Nina Raver-Shapira; Efi Marciano; Eti Meiri; Yael Spector; Nitzan Rosenfeld; Neta Moskovits; Zvi Bentwich; Moshe Oren
Journal:  Mol Cell       Date:  2007-05-31       Impact factor: 17.970

9.  Effects of internal low-dose irradiation from 131I on gene expression in normal tissues in Balb/c mice.

Authors:  Emil Schüler; Toshima Z Parris; Nils Rudqvist; Khalil Helou; Eva Forssell-Aronsson
Journal:  EJNMMI Res       Date:  2011-11-28       Impact factor: 3.138

10.  Altered radiation responses of breast cancer cells resistant to hormonal therapy.

Authors:  Lidiya Luzhna; Anne E Lykkesfeldt; Olga Kovalchuk
Journal:  Oncotarget       Date:  2015-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.